NovoCure
NVCR
NVCR
310 hedge funds and large institutions have $5.94B invested in NovoCure in 2021 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 124 increasing their positions, 91 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
310
Holders Change
-6
Holders Change %
-1.9%
% of All Funds
4.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
57
Increased
124
Reduced
91
Closed
61
Calls
$124M
Puts
$119M
Net Calls
+$5.35M
Net Calls Change
-$54.6M
Top Buyers
Top Sellers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$35.4M |
2 |
DCP
Darsana Capital Partners
New York
|
-$33.1M |
3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$20.1M |
4 |
First Trust Advisors
Wheaton,
Illinois
|
-$15.9M |
5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$12.6M |